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An animal model involving the subcutaneous implantation of tissue cages into guinea
pigs and subsequent infection with Staphylococcus aureus was used to study factors
pertinent to foreign body infection. Whereas 108 colony-forming units (cfu) of
S. aureus strain Wood 46 did not produce any abscesses in the absence of foreign
material, 102 cfu was sufficient to infect 95070 of the tissue cages despite the presence of
polymorphonuclear leukocytes (PMNLs) in sterile tissue cage fluid. Opsonization of
S. aureus by tissue cage fluid was adequate during the first hour of infection, but op-
sonic coating of the organisms decreased at 20 hr after the induction of infection.
PMNLs from sterile tissue cage fluid showed decreased phagocytic and bactericidal ac-
tivities when compared with PMNLs from either blood or peritoneal exudate obtained
after short- or long-term stimulation (P < 0.001).
The enhanced risk of bacterial infections in the
vicinity of a foreign body - such as sutures and
metallic or polymeric implants - has been re-
peatedly documented in cardiovascular [1-3], or-
thopedic [4-6], plastic reconstructive [7], and
general [8] surgery. Staphylococcus aureus,
Staphylococcus epidermidis, and Escherichia coli
are most frequently implicated as the etiologic
agents [9]. Foreign body infection proceeds by two
possible routes: early infection, due to local
bacterial contamination during surgery [4], and
late infection, after occasional seeding of micro-
organisms by the hematogenous route [6]. Both
types of infections, once established, rarely heal,
and excision of the foreign body remains the only
effective treatment.
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The factors responsible for the enhanced risk of
bacterial infection of foreign bodies are not well
understood. Ineffectiveness of local host defense
mechanisms against pyogenic organisms is sug-
gested by the classical experiments of Elek and
Conen [10], James and MacLeod [11], and Noble
[12], which showed that infection could be pro-
duced with as few as 100 cfu of S. aureus in the
vicinity of silk sutures. Although polymorpho-
nuclear leukocytes (PMNLs) accumulating around
a foreign body appear microscopically normal,
their functional status as well as the opsonizing
capacity of the surrounding fluid have never been
explored because of the lack of an appropriate
animal model. In the present communication we
describe the development of an animal model that
reproduces the clinical characteristics of a foreign
body infection and thus allows the in vitro evalua-
tion of the various phagocytic steps in its neigh-
borhood [13-16].
Materials and Methods
Tissue cages, animals, and implantation of
tissue cages. Rigid polymethacrylate and poly-
tetrafluoroethylene tubes (internal and external
diameters, 10 and 12 mm, respectively; length, 32
mm) were perforated by "-1250 regularly spaced
holes (diameter, 1 mm) and sealed at each end
with a cap of identical material.
Tricolor guinea pigs weighing 500-600 g each
which were allowed free access to food and which
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were housed individually were used throughout
the experiments. After im induction of a neurolep-
tanalgesia (0.1 ml/100 g of body weight; Hyp-
norms; Duphar, Amsterdam), a 4-cm incision was
made with an aseptic technique, and the sc space
was dissected bluntly. One gas-sterilized tissue
cage was implanted in each flank [17-20], and the
skin was closed with metal clips, which were
removed five days after surgery. The animals were
used for experimentation twp or more weeks after
implantation of the tissue cages, after full healing
of the incision.
Cytologic, microbiologic, and protein deter-
minations. Erythrocytes and leukocytes from
freshly obtained tissue cage fluids were counted in
a hemacytometer with trypan blue and Turk's
stain, respectively. Cell viability was evaluated by
exclusion of trypan blue. Quantitative bacterial
cultures were performed on Mueller-Hinton agar,
after lysis of PMNLs and appropriate serial dilu-
tions in sterile water. Possible dumping of
bacteria was checked for regularly and found to be
minimal under these experimental conditions. The
absence of spontaneous bacterial contamination
of tissue cage fluids was confirmed by subcultur-
ing undiluted tissue cage fluid on blood agar and
incubating the plates for 48 hr. Protein was quan-
titated by the Bio-Rad'" protein assay (Bio-Rad
Laboratories, Richmond, Calif.).
Collection and storage ofserum and tissue cage
fluid. Blood was obtained by cardiac puncture
and allowed to clot at 37 C for 30 min. Serum was
separated thereafter by centrifugation at 1,500 g
for 10 min at 4 C, stored at -70 C, and tested
within three months. Tissue cage fluid was col-
lected by percutaneous aspiration, added to ice-
cold siliconized glass tubes, centrifuged, and
stored under the same conditions as serum. Pools
of either serum or tissue cage fluid were obtained
by mixing such samples from at least five healthy
guinea pigs.
Experimental infections. S. aureus strain Wood
46, stored in aliquots of the same initial culture at
- 70 C, was used for all experiments. Overnight
cultures in Mueller-Hinton broth were washed and
resuspended in 0.9070 NaCI; 0.1 ml of an appro-
priate dilution was injected into tissue cages, sc
tissue, or the peritoneal cavity. The number of
viable bacteria injected was checked by plating 0.1
ml of a 10-6 dilution of the washed overnight
culture, which contained 7-15 x 108 cfu/ml.
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In addition, the following infections were at-
tempted under identical experimental conditions:
(1) inoculation of sc cavities created by surgical ex-
traction of tissue cages implanted four weeks
previously; (2) inoculation of sc, longitudinally-
halved tissue cages, thus allowing granulation
tissue to grow on either side of the cage wall; or (3)
before inoculation S. aureus strain Wood 46 was
preopsonized by incubation with 10070 serum for
30 min at 37 C, followed by two washes with 0.9%
NaCl. The efficacy of the preopsonization pro-
cedure was assessed in an in vitro phagocytic assay
without further addition of opsonins (serum or
tissue cage fluid).
Preparation of leukocytes. Acute peritoneal
exudates rich in PMNLs (>95%) were obtained
from guinea pigs by ip injections of either 12%
(wtlvol) sterile caseinate in 0.9% NaCI [21] or
0.1% (wtlvol) sterile glycogen in 0.9070 NaCI [22].
Persistent peritonitis as a paradigm for a chronic
exudate in the absence of a foreign body was pro-
duced by repeated injections of glycogen over a
period of two weeks. After such a sustained
stimulus, these exudates showed the same leuko-
cyte differential count as tissue cage fluid - 40%
PMNLs and 60070 mononuclear leukocytes; histo-
pathologic examination of sections confirmed the
presence of a chronic inflammation. The exudates
were collected by abdominal lavage with an
18-gauge needle and were filtered through four
layers of gauze (pore size, 1 x 2 mm) into ice-cold
siliconized glass tubes. The cell suspensions were
washed three times in cold 0.9% NaCI by cen-
trifugation at 150 g for 10 min and resuspended in
5 ml of a solution of phosphate-buffered saline
(Dulbecco's Gibco-Bio-Cult Co., Glasgow, Scot-
land). The total yield of PMNLs harvested by
these techniques usually exceeded 108 cells (>95 %
PMNLs) per animal with acute peritonitis and 6 x
107 cells (f\J40070 PMNLs) per animal with persis-
tent peritonitis. PMNLs from blood were ob-
tained as a 60070-80070 pure suspension by the
method described by Chenoweth et al. [23].
PMNLs from sterile tissue cage fluid were
aspirated percutaneously from tissue cages (two to
five weeks after surgery) and washed as described
above. When necessary, PMNLs were concen-
trated by centrifugation or by pooling cells from
two tissue cages from the same animal. PMNLs
from infected tissue cages were aspirated with the
same technique, washed, and resuspended in
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phosphate-buffered saline. This procedure as well
as the dilution of the cell suspension to an ap-
propriate concentration of PMNLs for the phago-
cytic assay decreased the number of bacteria pres-
ent in infected tissue cage fluid from 106 to 104
cfu/ml-that is, to 0.3070 of the number of in-
dicator bacteria used in the assay.
Phagocytic bactericidal assay. The same phag-
ocytic bactericidal assay previously described by
our laboratory [13, 24], was used throughout the
present study to measure opsonic activities of
tissue cage fluid and serum, the opsonic coating of
S. aureus in the animal model, and the overall kill-
ing by as well as the ingestion rate of PMNLs.
Opsonic activity. An overnight culture of
S. aureus strain Wood 46 was washed three times
in distilled water by centrifugation at 3,000 g for
10 min and finally resuspended in 1 ml of 0.9%
NaC1. Under such conditions, most bacteria ap-
peared as single cocci on Gram stain, thus
minimizing errors in cfu enumeration due to
clumping, as we have shown previously [13, 24,
25]. Guinea pig PMNLs, bacteria, and the opsonic
source to be tested were suspended in phosphate-
buffered saline in siliconized glass tubes in a final
volume of 1 ml. Each 1 ml of incubation mixture
contained 5 x 106 PMNLs, 1.5-3 x 106 cfu of
S. aureus, and 0.1 ml of a serially diluted source of
opsonins. The incubation and plating conditions
have been described [13, 24, 25]. The reciprocal
value of the dilution of serum or tissue cage fluid
that gave 50070 killing of S. aureus was defined as
the opsonic titer [13, 24]. Controls included (1)
heat-inactivated (at 56 C for 30 min) pooled serum
or tissue cage fluid with PMNLs; (2) PMNLs
without serum or tissue cage fluid; and (3) 10070
pooled serum without PMNLs. None of these con-
trols exhibited any bactericidal activity against the
test strain. The lack of bacterial killing with heat-
inactivated serum as the opsonic source confirmed
the previously defined opsonic requirements of
S. aureus strain Wood 46 [13, 24, 26].
Opsonic coating of bacteria. Experimentally
infected tissue cage fluids were aspirated 1 and 20
hr after inoculation of bacteria, and the opsonic
coating of the bacteria was assessed as follows.
The microorganisms were washed three times in
0.9% NaCI and resuspended in phosphate-buf-
fered saline. For each assay 0.5 ml of this bacterial
suspension was added to a suspension of 0.5 ml of
peritoneal PMNLs (5 x 106 ) in phosphate-buf-
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fered saline and incubated without addition of any
other opsonic source at 37 C in a shaking water
bath. Samples of the test suspension were taken at
zero-time and after 30 min of incubation, and
bacterial survival was determined as described
above. Simultaneous controls were obtained. by
preopsonizing an aliquot of the same bacterial
suspension with either 10% heat-inactivated (at
56 C for 30 min) or 10070 freshly obtained serum.
Preopsonization of the bacteria with heat-in-
activated serum did not increase the bacterial kill-
ing measured in the phagocytic bactericidal assay.
Phagocytic bactericidal capacity of PMNLs.
The testing of the phagocytic bactericidal poten-
tial of PMNLs obtained from tissue cage fluids or
peritoneal exudates presupposed that the opsonic
source used in the phagocytic assay was not rate-
limiting. This requirement was met by using
~2.5% pooled serum or ~lOOJo sterile tissue cage
fluid as the opsonic source [27].
Because PMNLs in tissue cages were unable to
eliminate inocula as small as 102 cfu of S. aureus
(see below), we assessed the in vitro bactericidal
performance of 2 x 106 PMNLs/ml not only with
the conventional inoculum (4 X 106 cfu), but also
with a smaller inoculum of 8 x 103 cfu. After in-
cubation of this suspension with 0.2 ml of pooled,
sterile tissue cage fluid at 37 C in a shaking water
bath, samples were drawn at zero-time and 30,
120, and 240 min, diluted, mixed with an equal
volume of 0.2070 Triton X-100 [25], and plated on
Mueller-Hinton agar. Each test was accompanied
by the following controls: (1) 20070 heat-in-
activated tissue cage fluid, which did not promote
any bacterial killing, and peritoneal PMNLs, and
(2) 20070 freshly obtained tissue cage fluid without
PMNLs, which led to bacterial growth after 2 and
4 hr of incubation in all tubes. In this modified
assay, control PMNLs exhibited killing capacity
which was within the ranges of the standard assay.
Control experiments with either 10070 serum or
400/0 tissue cage fluid as an opsonic source were
also performed and showed identical killing rates
in the presence of PMNLs. Moreover, preincuba-
tion of 400/0 tissue cage fluid with PMNLs from
blood, tissue cages, or exudates did not inhibit the
cells' phagocytic bactericidal function. Finally,
because for technical reasons PMNLs from tissue
cages could not be separated from other
leukocytes from tissue cages before the in vitro
assays, an inhibitory effect of the latter cells on
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PMNL function was excluded by appropriate mix-
ing experiments with tissue cage cells and control
PMNLs from peripheral blood.
Ingestion rate of PMNLs. Ingestion rates of
PMNLs were tested in a similar phagocytic assay
with use of lysostaphin [25, 28, 29]. In brief, this
assay consisted of incubating 5 x 106 PMNLs
with 1 x 107 cfu of S. aureus strain Wood 46 and
determining the overall killing in an aliquot after
30 min of incubation. Intracellular survival was
assessed by incubation for another 30 min in the
presence of 20 units of lysostaphin (Sigma
Chemical Co., St. Louis), followed by treatment
with 0.250/0 trypsin (Serva-Feinbiochemica, Heidel-
berg, Federal Republic of Germany) and neutrali-
zation of the proteolytic activity with 100/0 serum.
Complement studies. Total hemolytic comple-
ment activity was measured in a manual assay [30]
and expressed as the reciprocal dilution that gave
50% hemolysis of sensitized red blood cells (CHso).
C3 levels were quantitated by single radial immu-
nodiffusion with goat monospecific antibody to
guinea pig C3 (Cappel Laboratories, Cochran-
ville, Pa.) [31]. Values were expressed as percent-
ages of the level in pooled normal guinea pig
serum.
Statistical analysis. The significance of dif-
ferences between mean values was determined by
Student's r-test; the method of paired comparisons
was used when appropriate (that is, comparison of
opsonic coating at different conditions). For cor-
relation analysis, the Spearman's correlation coef-
ficient was used. Results were expressed as means
± SEM.
Results
Composition of normal, sterile tissue cagefluid
and histopathology of the inflammatory reaction.
After implantation of tissue cages, aspirated fluid
showed the following characteristics. Erythrocyte
counts decreased from 1.5 x 10S/ml (range,
0.3-3.6 x 108) at two weeks after surgery to 1 x
107/ml (range, 0.6-9 x .107 ) at 12 weeks after
surgery. Leukocyte counts decreased from 2.4 x
106/ml (range, 0.3-8.4 X 106) at two weeks after
surgery to 1 x 10s/ml (range, 0.5-8 X 105) at 12
weeks after surgery. Differential cell counts per-
formed two weeks after implantation of tissue
cages showed a slight predominance of PMNLs
(600/0 PMNLs and 40% mononuclear leukocytes),
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as opposed to two months later (30070 PMNLs and
70% mononuclear leukocytes).
Histologic sections examined four weeks after
implantation of tissue cages and stained with
hematoxylin and eosin showed a richly vascu-
larized granulation tissue containing lymphocytes,
fibroblasts, and collagen fibers in close contact
with the foreign body. There was heavy PMNL in-
filtration in the vicinities of infected tissue cages.
Biochemical determinations of levels of calcium,
magnesium, phosphorus, and zinc, pH, P02, and
pC02 confirmed the results obtained in other
animal species [19, 32]. The protein concentration
in tissue cage fluid decreased from 33.0 ± 1.4
g/liter at two weeks to 22.8 ± 1.1 g/liter at 11
weeks. These values were significantly lower in
tissue cage fluid than in serum (52.3 ± 0.9 g/liter)
at any postoperative interval tested (P < 0.001).
Induction of infection in tissue cages and deter-
mination of the minimal injecting dose. To de-
termine whether implantation of tissue cages is a
representative model of foreign body infection, it
had to be shown that the minimal infecting dose
was close to the values observed in other systems
[10-12]. For this purpose, the minimal infecting
dose - defined as the number of cfu of S. aureus
strain Wood 46 leading to a 95% infection rate-
was determined for tissue cage fluid, as well as for
sc tissue in the absence of a foreign body. Washed
bacterial cultures were injected into tissue cage
fluids or sc between weeks 2 and 13 after surgery.
Inocula as small as 102 cfu (range, 46-210 cfu)
produced infections in 44 (95.6%) of 46 of the
tissue cages at 24 hr, as determined macroscopical-
ly and by bacterial cultures, and inoculation of
~103 cfu of S. aureus resulted in an infection in 40
of 40 tissue cages. The minimal infecting dose was
identical whether polymethacrylate or poly tetra-
fluoroethylene tissue cages were used. Autopsies
of six animals showed the infection to be confined
to the space within and around the tissue cage,
without any evidence of spread to other organs;
blood cultures were negative. In contrast, no in-
fection could be produced in 30 animals by sc in-
jection of 10LI08 cfu of S. aureus strain Wood 46
in the absence of tissue cages. Ten animals were
used as microbiologic controls for the sterility of
sc tissue. For this purpose, the area of diffusion of
the inoculated bacteria was determined in prelimi-
nary experiments with Evan's blue (Hoffmann-La
Roche, Basel, Switzerland). After injection of the
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Figure 1. Viable leukocyte counts in tissue cage fluid
during experimental infection of guinea pigs with Staph-
ylococcusaureus strain Wood 46. At zero-time (arrow),
the indicated inocula were given: (0) 102 cfu (seven
animals), (e) 104 cfu (four animals), (.6.) 106 cfu (four
animals), and (A.) 108 cfu (two animals). Data are mean
+ SEM (bars) numbers of leukocytes x 1,OOO/jJI at inter-
vals after infection.
infection. Bactericidal activity of PMNLs. Be-
cause tissue cages could be infected with as few as
102 cfu of S. aureus despite the presence of 1 x
104-5 X 106 PMNLs/ml, we concluded that the
presence of a tissue cage promoted infection even
when the bacteria: PMNL ratio varied from
1 : 100 to 1: 50,000. We therefore examined
PMNLs from sterile tissue cages as to their
bactericidal function over various incubation
times with various bacterial inocula and compared
the data with the bactericidal activity of PMNLs
from either peripheral blood or peritoneal exu-
dates - that is, unstimulated or attracted PMNLs.
Finally, to compare exudates of similar age, the
function of PMNLs from tissue cages was com-
pared for each experimental condition with that of
peritoneal PMNLs obtained after two weeks of
stimulation.
The bactericidal activity of tissue case-derived
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various bacterial inocula, the area corresponding
to the previously determined diffusion zone was
biopsied, homogenized, and checked for bacterial
growth. All the biopsy specimens were sterile at 72
hr after injection of inocula as large as 108 cfu.
Evaluation of the role of tissue cage dead space.
Because the dead space present within tissue cages
could create unfavorable conditions for surface
phagocytosis, the following control experiments
were carried out. Tissue cages were halved
longitudinally and implanted as described. Histo-
logic examination confirmed that granulation
tissue had gained access to either side of the
foreign body. Five of five of these modified tissue
cages could still be infected with <10 3 organisms.
The negligible role of the dead space in promoting
infection was further demonstrated by removing
implanted, sterile tissue cages after four weeks and
inoculating the healed sc pouches after removal of
the clips with S. aureus strain Wood 46 suspended
in 4 ml of 0.9010 NaCl. In seven animals no infec-
tion could be produced with 109 cfu, and in six
animals the peritoneal cavity (a natural dead
space) could not be infected with 109 cfu.
Bacterial growth and leukocyte accumulation
during experimental infections of tissue cages.
To assess the development of infection in the ex-
perimental model, quantitative cultures of S. aureus
strain Wood 46 were performed in tissue cages
over seven days with various initial inocula. At 22
hr after inoculation of from 102 to 108 cfu,
bacteria reached concentrations ranging from 1.3
X 105 cfu/ml to 5.2 x 107 cfu/ml, respectively.
Further observations over two to seven days
showed that bacterial counts fluctuated between
105 cfu/ml and 108 cfu/ml, regardless of the initial
inoculum. These values were lower than those ob-
tained under in vitro conditions in Mueller-Hinton
broth (7-15 X 108 cfu/ml after 24 hr).
Quantitation of viable (trypan blue-negative)
leukocytes in tissue cage fluid at induction and
during establishment of infection with various in-
ocula is shown in figure 1. The observed increase
in leukocyte counts depended markedly on the in-
oculum size and on the time elapsed after inocula-
tion, with a lag phase of 2-8 hr. At 22 hr,
leukocyte counts had increased by factors of
5.1- and 40A-fold from initial inocula of 102 and
108 bacteria, respectively.
Phagocytic bactericidal activity of PMNLs
from tissue cagefluid in the absence or presence of
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PMNLs was considerably lower than activities ob-
served with PMNLs from acute and chronic
peritoneal exudates and from peripheral blood
(figure 2). This difference was significant with
each bacterial inoculum and at each incubation in-
terval tested, a result suggesting that the residen-
tial PMNLs in tissue cages were unable to cope
with S. aureus strain Wood 46, even at minimal in-
ocula. The viabilities of PMNLs from tissue cages,
blood, and peritoneal exudate before and after in-
cubation were comparable. Differential counts of
leukocytes from tissue cages showed 40070-70%
PMNLs and 30070-60070 mononuclear leukocytes;
these numbers were comparable to those obtained
from persistent peritoneal exudates. In contrast to
these results, in 10 assays the overall bactericidal
activity of PMNLs accumulating in experimental-
ly infected tissue cages at 20 hr after inoculation
was 91.3% ± 1.9070 when tested by standard
bactericidal procedure. Similar results were re-
corded with control PMNLs from peritoneal exu-
dates produced with glycogen or caseinate (bac-
tericidal activity, 86.1 % ± 2.4% [16 animals] and
79.6% ± 3.9% [10 animals], respectively).
Ingestion rates of PMNLs from sterile tissue
cages. To define further the overall bactericidal
defect observed with PMNLs from sterile tissue
cage fluid, we measured their ingestion rate as well
as their intracellular killing rate. In five animals,
PMNLs from tissue cages ingested 49.6070 ± 2.3%
and killed 39.1 % ± 1.6% of the S. aureus,
whereas peritoneal PMNLs ingested 87.2070 ±
2.2% and killed 83.1 % ± 2.5070 of the bacteria.
After determination of the number of ingested
bacteria, it could be calculated that 21.1 % ±
0.5070 of the ingested organisms remained viable in
PMNLs from tissue cages, whereas only 4.7% ±
0.5% of the bacteria ingested by control PMNLs
survived intracellularly after 30 min of incubation.
Opsonic activity and complement levels of
tissue cage fluid in the absence or presence of in-
fection. After having identified a phagocytic and
bactericidal defect in PMNLs from tissue cages,
we analyzed another component of the phagocytic
system- opsonization of the infecting organism.
Figure 3 shows complement-mediated opsonic ac-
tivity and total hemolytic complement levels in
sterile tissue cage fluids, expressed as 50% killing
and CHso units, measured at various intervals after
surgery. Both values in tissue cage fluid decreased
progressively with time, the opsonic activity being
14.4% and the complement level being 14.8% of
the serum values at 75 days after surgery. When
expressed per gram of protein, the values of the
tissue cage fluids corresponded to 33.1 % and
34.00/0 of the serum values, respectively. The cor-
relation in 30 animals between the total hemolytic
complement level and the opsonic titer was highly
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Figure 3. Opsonic activity and to-
tal hemolytic complement level in tis-
sue cage fluid from guinea pigs at in-
tervals after implantation and in
pooled normal guinea pig serum.
Data are means ± SEM (bars) of the
reciprocal dilutions that gave either
50070 killing of bacteria in a phago-
cytic assay (K50) or 50% hemolysis in
a hemolytic system (CH50). One as-
terisk indicates P< 0.01, and two as-
terisks indicate P < 0.001 in compari-
son with values in tissue cage fluid at
15 days after surgery.
significant (r = 0.81; P < 0.001). In 43 animals,
the mean ± SEM C3 level in tissue cage fluid was
18.60/0 ± 0.40/0 of the serum level.
In view of these low levels of 500/0 killing, CHso,
and C3 in tissue cage fluid, we considered the
possibility that this fluid might be unable to pro-
mote adequate opsonization, as has been de-
scribed for empyema [13]. To test this hypothesis,
S. aureus strain Wood 46 was preopsonized in
vitro with pooled guinea pig serum before inocula-
tion into tissue cages. Preopsonization of bacteria
was confirmed by incubating an aliquot with
peritoneal exudate PMNLs for 30 min in a phago-
cytic assay which led to a killing rate of 80%.
Despite optimal preopsonization, aliquots corre-
sponding to 1.2 x 102 cfu injected into sterile
tissue cages led to infection in four of four
animals. Although the kinetics of bacterial growth
and death were not formally tested in these experi-
ments, low opsonic activity in tissue cage fluid
could not be considered as a rate-limiting factor
favoring the development of infection. During the
development of infection, opsonic activity and the
complement level were measured at 1 and 20 hr
after inoculation of 107, cfu. The value of CHso in
six animals decreased moderately, from 267 ±
35.2 units to 172 ± 41.3 units (P < 0.025). Op-
sonic activity bound to S. aureus, however,
showed a striking change during the course of the
infection. In 20 animals, the opsonic coating of
bacteria (figure 4, left) promoted 75.3% ± 2.9%
killing at 1 hr after infection, whereas killing was
decreased to 46.7% ± 7.40/0 at 20 hr (P < 0.001).
The opsonic coating of S. aureus could be im-
proved (figure 4, middle) at 20 hr after infection
by injection of 0.5 ml of fresh autologous serum
(final concentration, 25%) into infected tissue
cages, as demonstrated by aspirating the infecting
bacteria 60 min after injection of fresh serum into
tissue cages and testing the staphylococci in a
phagocytic assay against peritoneal exudate
PMNLs. In five assays, killing of these reop-
sonized bacteria improved from 35.30/0 ± 12.4070
to 71.6% ± 4.1% (P< 0.01). Finally, the opsonic
coating of S. aureus at 20 hr was poor (figure 4,
right) regardless of the size of the initial inoculum,
which varied from 103 cfu to 108 cfu. In 12 assays,
killing of aspirated S. aureus could be improved
from 38.2% ± 5.3% to 88.8% ± 2.0% (P <
0.001) by in vitro reopsonization with 100/0 pooled
guinea pig serum. In summary, these experiments
suggest that opsonic coating of S. aureus strain
Wood 46 is incomplete at 20 hr after infection and
that this defect can be corrected by addition of
fresh guinea pig serum either into the tissue cage
or to the phagocytic assay.
Discussion
The factors promoting foreign body infection are
not well understood. In this report we have
described an experimental guinea pig model that
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Figure 4. Opsonic activity bound
to Staphylococcus aureus strain
Wood 46 at intervals after experi-
mental infection of tissue cages in
guinea pigs: (left) 1 and 20 hr after in-
fection with 107 cfu; (middle) 20 hr
after infection with 107 cfu before
and after in vivo supplementation of
tissue cage fluid with 0.5 ml of fresh
autologous serum (final concentra-
tion, 25%); and (right) 20 hr after in-
fection with (0) 103 cfu, (e) 104 cfu,
(~) 106 cfu, and (A.) 108 cfu before
and after in vitro reopsonization with
10010 pooled serum for a 30-min peri-
od. Data are percentages of killing of
S. aureus isolated from infected tis-
sue cages after incubation for 30 min
in a phagocytic assay with 5 x 106
polymorphonuclear leukocytes from
peritoneal exudate.
permits exploration of these factors and repro-
duces the main characteristics observed in its
clinical counterpart. After sc implantation of
polymer tissue cages, injection of 102 cfu of an
organism of low virulence such as S. aureus strain
Wood 46 led uniformly to local infection in <20
hr. Infection did not spread to any other organ
and healed after elimination of the foreign body.
These observations, as well as the generally ac-
cepted concept that the main host defense mecha-
nisms against local infections with S. aureus in-
clude opsonization and phagocytosis [13, 33], led
us to focus our analysis of these host factors only
over the first 20 hr of infection. S. aureus strain
Wood 46 was used in all experiments to avoid in-
terference of staphylococcal protein A with IgG;
this strain has been repeatedly shown to contain
negligible amounts of protein A [26, 34] and to re-
quire complement only for "optimal opsonization
[13, 24, 26]. Although several biochemical deter-
minations in tissue cage fluid differed from values
in serum (data not shown), their variations were
not sufficient to inhibit phagocytosis [35-39].
Such an effect, as well as a deleterious effect of
tissue cage fluid on PMNLs, was further ruled out
by appropriate mixing experiments involving pre-
incubation of tissue cage fluid with competent
blood PMNLs.
Our observations have identified two host
defense defects in the neighborhood of the foreign
body that are manifested at distinct stages in an in-
fection - namely, poor PMNL activity at the
beginning and a steadily decreasing efficiency of
opsonization during the course of the disease.
Initially, opsonization of strain Wood 46 was
adequate and could therefore, not account for the
high susceptibility to infection in our model.
Moreover, in vitro preopsonization of the infect-
ing strain did not prevent the development of in-
fection after inoculation into tissue cages. Our
data further suggest that at this early stage, the
PMNLs residing in sterile tissue cage fluid were
deficient in their phagocytic bactericidal function
when compared with control PMNLs from either
blood-the milieu from which they are originat-
ing - or peritoneal exudates obtained by a single
soluble stimulus. This defect could be demon-
strated under the standard conditions of a conven-
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tional phagocytic assay, as well as at a bacterial
PMNL ratio of 1 : 250, which was the condition
encountered in tissue cage fluid. Finally, this
phagocytic bactericidal deficit in PMNLs from
tissue cages tested two weeks after implantation
was also evident when these cells were compared
with PMNLs from an exudate of the same age,
produced by soluble stimuli administered over 14
days.
Several aspects of this phagocytic bactericidal
defect in PMNLs from tissue cages merit com-
ment. (1) The development of a control system
reproducing the conditions of a chronic exudate in
the absence of a foreign body was of importance
to compare the phagocytic function of PMNLs of
similar ages in the presence and the absence of a
foreign body. The identical time elapsed between
the onset of these protracted stimuli (tissue cages
or glycogen), the cytology of the two exudates,
and the results of histopathologic examination of
the two surrounding tissues suggest the presence
of cell populations of the same age. This issue,
however, can be resolved unambiguously only by
future experiments involving comparison of pulse-
labeled PMNLs; for the time being, comparison
of PMNLs from blood and exudate has been con-
sidered as an adequate procedure in similar ex-
periments [40]. (2) The observed phagocytic
bactericidal defect in PMNLs from tissue cages is
all the more striking because Van Epps and Garcia
have demonstrated that PMNLs from peritoneal
exudates of guinea pigs elicited by a soluble
stimulus actually show increased, rather than de-
creased, metabolic activity [40].
In keeping with our results obtained with
PMNLs from tissue cages, Klock and Bainton [41]
and Klock and Stossel [42]have demonstrated that
intimate contact of PMNLs with glass or nylon
wool will lead not only to activation of their ox-
idative metabolism and to degranulation, but also
to a decrease in the cells' phagocytic bactericidal
function. Electron microscopic data obtained with
our model have confirmed that PMNLs in close
contact with tissue cages show decreased granule
contents.' Degranulation and metabolic altera-
tions have been described for other systems in-
1 I. loris, W. Zimmerli, G. Majno, and F. A. Waldvogel,
"Foreign Body Reactions: Morphology of Inflammatory and
Phagocytic Cells," manuscript in preparation.
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volving PMNLs in contact with foreign, non-
phagocytosable surfaces [43-45]. Taken together,
these in vitro results suggest that intimate contact
of PMNLs with foreign, nonphagocytosable sur-
faces might be detrimental to these cells, as sug-
gested by the results of our experimental model.
Finally, the deficit observed in PMNLs from
tissue cages affected ingestion as well as bacteri-
cidal function, an observation suggesting that
several subcellular mechanisms are altered. The
mechanisms underlying these various alterations
remain to be defined.
In contrast to these observations for the early
stage of infection, opsonic coating of the infecting
microorganism S. aureus strain Wood 46- pre-
sumably by functional C3 [46] - was markedly de-
creased during the course of the infection. This
observation is open to at least two interpretations.
Either decreased opsonization of S. aureus might
be a consequence of the imbalance between the
rate of coating of bacteria with functionally active
C3 and the logarithmic growth of the organisms,
or cleavage of the opsonically active factor by
fJ-I-H-globulin, C3b inactivator, and proteases
[47-51] could have occurred during the develop-
ment of a purulent infection. Loss of opsonic ac-
tivity, as well as proteolytic cleavage of C3, has
been recently demonstrated in several exudates
rich in PMNLs [13, 15, 24]. Finally, our experi-
ments showed that PMNLs attracted into the in-
fected tissue cages displayed normal phagocytic
bactericidal function, a finding which is apparent-
ly in contradiction with our observations in sterile
tissue cages. In the case of a sterile tissue cage,
however, the foreign body itself is probably
responsible for the attraction of PMNLs; in the
case of an abscess, additional chemoattractants
such as bacterial polypeptides [52] are liberated,
thus allowing PMNLs to accumulate in the fluid
phase without being in contact with the foreign
body. Intimate contact of PMNLs with foreign
surfaces has indeed been shown to be necessary to
alter the cells' metabolism and phagocytic func-
tions [41, 42].
In conclusion, the phagocytic bactericidal
defect in PMNLs from sterile tissue cage fluid
probably represents one of the several deter-
minants of foreign body infection and allows
other pathogenic factors to progress during the
first hours of the disease. Some of these factors
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may include organic substances coating the
foreign body, which may protect bacteria from
phagocytosis [53]; bacterial adhesion to foreign
material [54]; and formation of a bacterial "gly-
cocalyx" [55], which reduces bacterial accessibility
to phagocytes and/or antibiotics. The animal
model described here should permit the investiga-
tion of these and other possible factors that
predispose foreign bodies to infection.
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